🇺🇸 Rituxan +CHOP in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Catheter Site Discharge — 1 report (16.67%)
  2. Catheter Site Erythema — 1 report (16.67%)
  3. Febrile Neutropenia — 1 report (16.67%)
  4. Hypotension — 1 report (16.67%)
  5. Nausea — 1 report (16.67%)
  6. Vomiting — 1 report (16.67%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Rituxan +CHOP approved in United States?

Rituxan +CHOP does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Rituxan +CHOP in United States?

Shandong New Time Pharmaceutical Co., LTD is the originator. The local marketing authorisation holder may differ — check the official source linked above.